Bassett Cancer Institute Earns National Accreditation from the Commission on Cancer of the American College of Surgeons
Bassett Cancer Institute has earned continuing accreditation from the Commission on Cancer, a national quality program of the American College of Surgeons. The accreditation maintains Bassett’s position as one of the longest standing Commission on Cancer accredited programs in the country. Bassett’s cancer program has been continuously accredited since 1947.
To achieve Commission on Cancer accreditation, the Bassett Cancer Institute underwent a rigorous site assessment to confirm the program’s compliance with accreditation standards that evaluate the cancer care services offered by the program.
“Congratulations to all, as this was truly a multidisciplinary team effort,” said Dr. Alfred Tinger, FACRO, Medical Director of the Bassett Cancer Institute. “To all the staff, Cancer Committee members and alternates, colleagues in Surgery, Pathology, Radiology, Palliative Care, Rehabilitation, Social Work, and Administration – we thank you for continuing to provide the best quality of care and support to our patients.”
“We are proud to continue meeting the Commission on Cancer’s high standards that allow us to maintain this important designation. At Bassett, we aim to not only meet such high clinical standards, but to exceed them whenever possible,” says Dr. Henry F. Weil, President, Bassett Medical Center, Chief Clinical & Academic Officer, Bassett Healthcare Network.
The Commission on Cancer is a consortium of professional organizations dedicated to improving survival and quality of life for patients with cancer by setting and raising standards. The organization promotes cancer prevention, research, education, and monitoring of comprehensive quality care.
As a Commission on Cancer-accredited cancer center, the Bassett Cancer Institute applies a multidisciplinary approach and treats cancer as a complex group of diseases that requires consultation among surgeons, medical and radiation oncologists, diagnostic radiologists, pathologists, and other healthcare professionals that specialize in caring for cancer patients. Patients also benefit from comprehensive supportive care from nutritionists, social workers, financial counselors, and nurse navigators to ensure that patients receive the highest level of comprehensive cancer care.
Continually advancing its mission of patient care, Bassett Healthcare Network is a clinical trial site for Alpha DaRT™, an investigational treatment for recurrent skin cancers, under the direction of Dr. Timothy Korytko, Bassett Healthcare Network Chief Radiation Oncologist, and Stephen Iorio, Chief Radiation Physicist and Radiation Safety Officer. Alpha DaRT™ is designed to deliver a highly potent radiation treatment for solid cancer tumors with localized precision without damaging surrounding healthy tissues.
Bassett is now also offering radiopharmaceutical treatments with two new therapies: Lutathera, a groundbreaking therapy that can dramatically improve outcomes for patients with neuroendocrine cancer, and Pluvicto, a targeted treatment for metastatic prostate cancer.
Other American College of Surgeons quality programs in which Bassett Healthcare Network participates include:
- The National Surgical Quality Improvement Program
- The Trauma Verification, Review, and Consultation Program
- The Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program
As stated on the American College of Surgeons’ website: “For more than 100 years, quality has been the cornerstone of the American College of Surgeons. As the preeminent voice on surgical quality in healthcare, American College of Surgeons sets the highest quality standards for surgeons and hospitals alike—and then works to exceed them.”
Learn more about the Bassett Cancer Institute by visiting bassett.org/cancer-care or calling 607-547-3336.
Explore ways to support Bassett Cancer Institute and Bassett Healthcare Network by visiting friendsofbassett.org or calling 607-547-3928.
PLATINUM INVESTORS
